Cover Image
市場調查報告書

院內傳染病檢查 (肺炎、UTI、血流感染、手術部位感染、MRSA感染、其他) 的全球產業分析、市場規模、市場佔有率、成長率、市場趨勢、市場預測 (2015 - 2023年)

Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 294640
出版日期 內容資訊 英文 85 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
院內傳染病檢查 (肺炎、UTI、血流感染、手術部位感染、MRSA感染、其他) 的全球產業分析、市場規模、市場佔有率、成長率、市場趨勢、市場預測 (2015 - 2023年) Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2015年12月24日 內容資訊: 英文 85 Pages
簡介

本報告提供全球院內傳染病檢查市場相關調查,市場成長的各種影響因素及市場機會分析,各檢驗區分、地區/主要國家的收益規模的變化與預測,建議,以及主要企業的簡介等彙整。

第1章 序論

第2章 摘要整理

  • 全球院內傳染病檢查市場各地區佔有率的預測
  • 全球院內傳染病檢查市場實際成果:各檢驗種類
  • 院內傳染病檢查市場概要

第3章 院內傳染病檢查市場:產業分析

  • 簡介
  • 市場促進因素
    • 政府的指南、醫療相關感染 (HAI) 防止規章的確立
    • HAI的發病率的擴大和藥物抗性病原菌的增加
  • 市場成長的阻礙要素
    • 嚴格的法律規章、指導架構
    • 發展中國家的統一控制機關、統一控制計劃的缺乏
  • 市場機會
    • 美國「Patient Care and Affordable Care Act」
    • 分子診斷領域的技術發展
  • 波特的五力分析
  • 市場魅力度分析:各地區

第4章 市場分析:各檢驗種類

  • 簡介
  • 全球院內傳染病檢查市場收益預測:各檢驗種類
    • 泌尿道感染檢驗
    • 手術部位感染檢驗
    • 肺炎感染檢驗
    • 血流傳染病檢查
    • 其他傳染病檢查

第5章 地區分析

  • 簡介
  • 全球院內傳染病檢查市場收益預測:各地區
  • 北美市場收益預測:各國
  • 北美市場收益預測:各檢驗種類
  • 歐洲市場收益預測:各國
  • 歐洲市場收益預測:各檢驗種類
  • 亞太地區市場收益預測:各國
  • 亞太地區市場收益預測:各檢驗種類
  • 南美市場收益預測:各國
  • 南美市場收益預測:各檢驗種類
  • 中東、非洲市場收益預測:各國
  • 中東、非洲市場收益預測:各檢驗種類

第6章 建議

第7章 企業簡介

  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • QIAGEN
  • Siemens Healthcare
  • Diatherix Laboratories, Inc.
  • Meridian Bioscience, Inc.
  • Thermo Fisher Scientific, Inc.(Life Technologies Corporation)
  • Cepheid, Inc.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. Morbidity rate of nosocomial infections is increasing rapidly worldwide, thereby driving the hospital associated infection(HAI) diagnostic market towards remarkable growth. The stakeholders for this study include manufacturers and providers of diagnostic solutions for nosocomial infections.

The global hospital acquired disease testing market is categorized on the basis of test types, i.e., urinary tract infection, surgical site infection, pneumonia, blood stream infection, MRSA infection, and others. A detailed market analysis and forecast for these segments has been provided in this study, in terms of market revenue(US$ Mn) for the period 2013 to 2023. The report also provides with the compounded annual growth rate(CAGR %) for each infection type for the forecast period 2015 to 2023, while market size estimations have been made considering 2014 as the base year.

In terms of geographical distribution, the global hospital acquired disease testing market has been classified into four geographical areas: North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. The current and future market sizes(in terms of US$ Mn) of the above regional markets have been provided in the report for the period 2013 to 2023 with their growth rate(%) for the period 2015 to 2023. The study further offers recommendations and highlights of the market, which would be useful for the current and future market players to sustain and grow in the global hospital acquired disease testing market.

The market overview section of the report demonstrates the market dynamics and market trends such as the drivers, restraints and opportunities that influence the current nature and future status of this field. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been explained in the market overview section of the report, in order to give a thorough analysis of the overall competitive scenario in the global hospital acquired disease testing market.

This report concludes with the company profiles section which includes key information about the major players in this market. Some of the key players profiled in this report include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

The global hospital acquired disease testing market is segmented as follows:

Global Hospital Acquired Disease Testing Market, by Test

  • Pneumonia infection
  • Urinary tract infection
  • Blood stream associated infection
  • Surgical site infection
  • MRSA infection
  • Others

Global Hospital Acquired Disease Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest pf APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents

Chapter 1 - Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

  • 2.1. Global Hospital Acquired Disease Testing Market Share, by Geography, 2014-2023(US$ Mn)
  • 2.2. Global Hospital Acquired Disease Testing Market, by Test, 2014(US$ Mn)
  • 2.3. Hospital Acquired Disease Testing Market Snapshot

Chapter 3 - Hospital Acquired Disease Testing Market - Industry Analysis

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Establishment of government guidelines and code for prevention of HAIs
    • 3.2.2. Increase in prevalence of HAIs and rise in the number of drug resistant pathogens
  • 3.3. Restraints
    • 3.3.1. Stringent regulations and guidance framework
    • 3.3.2. Lack of controlling authorities and control programs in less developed regions
  • 3.4. Opportunity
    • 3.4.1. Passage of the Patient Care and Affordable Care Act in the U.S.
    • 3.4.2. Technological development in the field of molecular diagnostics
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis- Hospital Acquired Disease Testing Market, by Geography(2014)(Value %)

Chapter 4 - Market Segmentation - By Test

  • 4.1. Introduction
  • 4.2. Global Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
    • 4.2.1. Global Urinary Tract Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.2. Global Surgical Site Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.3. Global Pneumonia Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.4. Global Bloodstream Infection Testing Market Revenue, 2013-2023(US$ Mn)
    • 4.2.5. Global Others Infection Testing Market Revenue, 2013-2023(US$ Mn)

Chapter 5 - Market Segmentation - By Geography

  • 5.1. Introduction
  • 5.2. Global Hospital Acquired Disease Testing Market Revenue, by Geography, 2013-2023(US$ Mn)
  • 5.3. North America Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.4. North America Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.5. Europe Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.6. Europe Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.7. Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.8. Asia Pacific Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.9. Latin America Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.10. Latin America Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)
  • 5.11. Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Country, 2013-2023(US$ Mn)
  • 5.12. Middle East & Africa Hospital Acquired Disease Testing Market Revenue, by Test, 2013-2023(US$ Mn)

Chapter 6 - Recommendations

Chapter 7 - Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Alere, Inc.
  • 7.3. Becton, Dickinson and Company
  • 7.4. bioMérieux SA
  • 7.5. F. Hoffmann-La Roche Ltd.
  • 7.6. Hologic, Inc.
  • 7.7. QIAGEN
  • 7.8. Siemens Healthcare
  • 7.9. Diatherix Laboratories, Inc.
  • 7.10. Meridian Bioscience, Inc.
  • 7.11. Thermo Fisher Scientific, Inc.(Life Technologies Corporation)
  • 7.12. Cepheid, Inc.
Back to Top